166 related articles for article (PubMed ID: 20024502)
21. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
[TBL] [Abstract][Full Text] [Related]
22. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
23. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
25. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.
Rezaie AR
J Biol Chem; 1998 Jul; 273(27):16824-7. PubMed ID: 9642241
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
Johnson DJ; Langdown J; Huntington JA
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
[TBL] [Abstract][Full Text] [Related]
28. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
29. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
[TBL] [Abstract][Full Text] [Related]
31. The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line.
Hamamoto T; Foster DC; Kisiel W
Int J Hematol; 1996 Jan; 63(1):51-63. PubMed ID: 8713577
[TBL] [Abstract][Full Text] [Related]
32. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
MacGregor IR; Lane DA; Kakkar VV
Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
[TBL] [Abstract][Full Text] [Related]
34. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide.
Quinsey NS; Whisstock JC; Le Bonniec B; Louvain V; Bottomley SP; Pike RN
J Biol Chem; 2002 May; 277(18):15971-8. PubMed ID: 11854268
[TBL] [Abstract][Full Text] [Related]
35. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
Blaskó G
Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
[TBL] [Abstract][Full Text] [Related]
36. Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.
Izaguirre G; Rezaie AR; Olson ST
J Biol Chem; 2009 Jan; 284(3):1550-8. PubMed ID: 19010776
[TBL] [Abstract][Full Text] [Related]
37. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
38. Role of arginine 129 in heparin binding and activation of antithrombin.
Desai U; Swanson R; Bock SC; Bjork I; Olson ST
J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
[TBL] [Abstract][Full Text] [Related]
39. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
[TBL] [Abstract][Full Text] [Related]
40. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
Ellis V; Scully MF; Kakkar VV
Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]